SD Biosensor Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	674,066	655,677	2,932,001	2,929,961	1,686,163	72,962
Other Revenue	-0	-0	-	-	-	-
Revenue	674,066	655,677	2,932,001	2,929,961	1,686,163	72,962
Revenue Growth (YoY)	-2.80%	-77.64%	0.07%	73.76%	2211.01%	-
Cost of Revenue	352,293	533,227	1,541,891	1,336,785	829,530	52,386
Gross Profit	321,774	122,449	1,390,110	1,593,176	856,633	20,576
Selling, General & Admin	195,117	206,811	169,176	177,655	102,344	12,154
Research & Development	78,600	64,203	45,762	19,086	10,388	4,869
Other Operating Expenses	3,016	2,810	3,527	1,571	716.9	330.52
Operating Expenses	387,374	370,534	243,486	205,443	118,369	19,056
Operating Income	-65,600	-248,085	1,146,624	1,387,733	738,264	1,520
Interest Expense	-66,159	-49,228	-994.06	-488.66	-433.63	-251.49
Interest & Investment Income	20,773	23,487	26,486	6,702	489.67	90.1
Currency Exchange Gain (Loss)	677.04	-22,710	92,362	65,296	-26,100	840.92
Other Non Operating Income (Expenses)	-1,488	-44,224	-12,500	-3,359	-487.1	212.73
EBT Excluding Unusual Items	-111,797	-340,759	1,251,979	1,455,883	711,734	2,412
Gain (Loss) on Sale of Investments	-2,019	3,059	547.95	12,282	6,084	-153.45
Gain (Loss) on Sale of Assets	4,431	-1,045	-1,804	-1,373	-580.55	-56.06
Asset Writedown	-99,869	-99,869	-8,634	-2,283	-	-
Pretax Income	-209,254	-438,614	1,242,088	1,464,509	717,237	2,202
Income Tax Expense	-146,671	29,290	333,300	376,385	95,623	-928.64
Earnings From Continuing Operations	-62,583	-467,904	908,789	1,088,124	621,614	3,131
Minority Interest in Earnings	-634.79	192.56	2,574	346.26	-5,978	22.08
Net Income	-63,218	-467,712	911,362	1,088,471	615,636	3,153
Net Income to Common	-63,218	-467,712	911,362	1,088,471	615,636	3,153
Net Income Growth	-	-	-16.27%	76.80%	19424.28%	-
Shares Outstanding (Basic)	122	111	101	98	93	82
Shares Outstanding (Diluted)	122	111	101	98	94	82
Shares Change (YoY)	15.69%	9.44%	3.87%	4.28%	13.56%	-
EPS (Basic)	-516.94	-4218.95	8996.76	11161.38	6597.15	38.29
EPS (Diluted)	-516.98	-4219.00	8996.76	11161.00	6583.00	38.00
EPS Growth	-	-	-19.39%	69.54%	17223.68%	-
Free Cash Flow	75,739	-384,884	587,008	1,044,892	440,478	-9,076
Free Cash Flow Per Share	619.32	-3471.82	5794.81	10714.52	4710.19	-110.21
Gross Margin	47.74%	18.68%	47.41%	54.38%	50.80%	28.20%
Operating Margin	-9.73%	-37.84%	39.11%	47.36%	43.78%	2.08%
Profit Margin	-9.38%	-71.33%	31.08%	37.15%	36.51%	4.32%
Free Cash Flow Margin	11.24%	-58.70%	20.02%	35.66%	26.12%	-12.44%
EBITDA	83,182	-110,543	1,187,444	1,406,848	746,239	5,850
EBITDA Margin	12.34%	-16.86%	40.50%	48.02%	44.26%	8.02%
D&A For EBITDA	148,782	137,541	40,820	19,115	7,974	4,331
EBIT	-65,600	-248,085	1,146,624	1,387,733	738,264	1,520
EBIT Margin	-9.73%	-37.84%	39.11%	47.36%	43.78%	2.08%
Effective Tax Rate	-	-	26.83%	25.70%	13.33%	-
Advertising Expenses	-	5,988	14,830	10,329	2,050	863.32

Source: S&P Capital IQ. Standard template. Financial Sources.